Evidence map›Paper›PMID 35816130›Full record

ReviewInflammatory bowel diseases2023

The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients.

Julia J Liu, Bincy P Abraham, Paula Adamson, Edward L Barnes, Kelly A Brister, Oriana M Damas, Sarah C Glover, Kimberly Hooks, Ana Ingram, Gilaad G Kaplan and 9 more

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Inflammatory bowel diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06424769 (Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06424769 naenrolling by invitationnot on this mapstarted 2024, after this paper: background citation

Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management (PROMOTE IBD)

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2024 to 2028Enrolled900ConditionsInflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, ColitisArmsEnhanced Digital Care, Education
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Treatment and Outcomes of Crohn's Disease and Ulcerative Colitis in Newly Diagnosed Adults in the United States, 2007 to 2023.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2026
    Article
  5. Article
  6. Article
  7. Ancestral Diversity in Pharmacogenomics Affects Treatment for Hispanic/Latine Populations With Inflammatory Bowel Disease.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 14 institutions in 2 countries.

Julia J LiuDivision of Gastroenterology, Morehouse School of Medicine, Atlanta, GA, USA.ORCID 0000-0002-1267-7452
Bincy P AbrahamDivision of Gastroenterology and Hepatology, Houston Methodist Academic Institute, Houston, TX, USA.
Paula AdamsonDivision of Gastroenterology, Morehouse School of Medicine, Atlanta, GA, USA.
Edward L BarnesDivision of Gastroenterology and Hepatology, UNC School of Medicine, Chapel Hill, NC, USA.
Kelly A BristerDepartment of Surgery, University of Mississippi Medical Center, Jackson, MS, USA.
Oriana M DamasDivision of Gastroenterology and Hepatology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Sarah C GloverDivision of Gastroenterology and Hepatology, University of Mississippi Medical Center, Jackson, MS, USA.
Kimberly HooksColor of Crohn's and Chronic Illness, Glenarden, MD, USA.
Ana IngramColor of Crohn's and Chronic Illness, Glenarden, MD, USA.
Gilaad G KaplanDivision of Gastroenterology and Hepatology, Department of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada.
Edward V LoftusDivision of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Dermot P B McGovernF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Melodie Narain-BlackwellColor of Crohn's and Chronic Illness, Glenarden, MD, USA.
Florence-Damilola OdufaluDivision of Gastroenterology and Liver Diseases, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
Sandra QuezadaDivision of Gastroenterology and Hepatology, University of Maryland, College Park, College Park, MD, USA.
Vonda ReevesGI Associates and Endoscopy Center, Jackson, MS, USA.
Bo ShenInflammatory Bowel Disease Center, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY, USA.
Thaddeus S StappenbeckDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Latonia WardColor of Crohn's and Chronic Illness, Glenarden, MD, USA.
Parents' Place of Maryland · USMorehouse School of Medicine · USCedars-Sinai Medical Center · USCleveland Clinic Lerner College of Medicine · USHouston Methodist · USJackson Memorial Hospital · USMayo Clinic in Arizona · USNewYork–Presbyterian Hospital · USUniversity of Calgary · CAUniversity of Maryland, College Park · USUniversity of Miami · USUniversity of Mississippi Medical Center · USUniversity of North Carolina Health Care · USUniversity of Southern California · US

Funding

The impact of diet patterns and PUFA-related polymorphisms on ulcerative colitis in HispanicsK23DK117054 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DAMAS, ORIANA MAZORRA · 2019 to 2023
$1.0M
NIDDK NIH HHS K23 DK117054
6 · The paper itself

Abstract

Research on the care of inflammatory bowel disease (IBD) patients has been primarily in populations of European ancestry. However, the incidence of IBD, which comprises Crohn's disease and ulcerative colitis, is increasing in different populations around the world. In this comprehensive review, we examine the epidemiology, clinical presentations, disease phenotypes, treatment outcomes, social determinants of health, and genetic and environmental factors in the pathogenesis of IBD in Black and Hispanic patients in the United States. To improve health equity of underserved minorities with IBD, we identified the following priority areas: access to care, accurate assessment of treatment outcomes, incorporation of Black and Hispanic patients in therapeutic clinical trials, and investigation of environmental factors that lead to the increase in disease incidence.

Indexed as

Colitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesBlack or African AmericanHispanic or LatinoHumansIncidencedisparityoutcomespathogenesis

Identifiers

PMID35816130
PMCPMC10210746
OpenAlexW4285009614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.